Patents by Inventor Tamer Elbayoumi

Tamer Elbayoumi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nourexin-4 nano-lipid emulsions
    Patent number: 8333987
    Abstract: The present invention provides compositions and methods for identifying, monitoring, and/or treating tissue inflammation caused by diseases or injury. Inflammatory mediators from the Nourin family are provided as diagnostic markers to detect or monitor a disease or injury that results in inflammation. In addition, the Nourin family antagonist, Nourexin-4 is provided as a therapy to treat diseases or injury. Further, cyclocreatine is provided as an inhibitor of Nourin formation, which can be used as a therapy to treat injury and inflammation.
    Type: Grant
    Filed: September 30, 2009
    Date of Patent: December 18, 2012
    Inventors: Salwa Elgebaly, Elliott Schiffmann, Tamer Elbayoumi
  • NANOEMULSION FORMULATIONS FOR DIRECT DELIVERY
    Publication number: 20110045050
    Abstract: A nanoemulsion and corresponding methods of making and using systems of single or blended high HLB value surfactant(s) for the emulsification of single or blended oils and vitamin E components in an aqueous phase are provided. The resulting nanoemulsions and methods of administering the nanoemulsions, including a corresponding kit, provide delivery of the nanoemulsions to a patient.
    Type: Application
    Filed: August 24, 2009
    Publication date: February 24, 2011
    Applicant: ATRIUM MEDICAL CORPORATION
    Inventors: Tamer A. Elbayoumi, Fonghsu Kuo, Paul Martakos, Keith M. Faucher
  • NOURIN AND NOURIN ANTAGONISTS
    Publication number: 20100119594
    Abstract: The present invention provides compositions and methods for identifying, monitoring, and/or treating tissue inflammation caused by diseases or injury. Inflammatory mediators from the Nourin family are provided as diagnostic markers to detect or monitor a disease or injury that results in inflammation. In addition, the Nourin family antagonist, Nourexin-4 is provided as a therapy to treat diseases or injury. Further, cyclocreatine is provided as an inhibitor of Nourin formation, which can be used as a therapy to treat injury and inflammation.
    Type: Application
    Filed: September 30, 2009
    Publication date: May 13, 2010
    Inventors: Salwa ELGEBALY, Elliott Schiffmann, Tamer Elbayoumi